<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Baumann CA</dc:creator>
  <dc:creator>Mu L</dc:creator>
  <dc:creator>Johannsen S</dc:creator>
  <dc:creator>Honer M</dc:creator>
  <dc:creator>Schubiger PA</dc:creator>
  <dc:creator>Ametamey SM</dc:creator>
  <dc:date>2010</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The metabotropic glutamate receptor subtype 5 (mGluR5) is recognized to be involved in numerous brain disorders. In an effort to obtain a fluorine-18 labeled analogue of the mGluR5 PET tracer [(11)C]ABP688, 13 novel ligands based on the core structure of ABP688 were synthesized. Molecules in which the methyl group at the oxime functionality of ABP688 was replaced by fluorobenzonitriles, fluoropyridines, and fluorinated oxygen containing alkyl side chains were investigated. Substituents at the oxime functionality are well tolerated and resulted in five candidates with K(i) values below 10 nM. The most promising candidate, (E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone-O-2-(2-fluoroethoxy)ethyloxime (38, K(i) = 3.8 nM), was radiolabeled with fluorine-18. Scatchard analysis of [(18)F]38 which modeled best for two sites pointed to high binding affinity (K(D1) = 0.61 +/- 0.19 nM and K(D2) = 13.73 +/- 4.69 nM) too. These data strongly suggest the further evaluation of [(18)F]38 as a candidate for imaging the mGluR5.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/143170</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1021/jm901850k</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/20411954</dc:relation>
  <dc:source>Journal of medicinal chemistry. - 2010</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Alkynes</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Binding, Competitive</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Brain</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Fluorine Radioisotopes</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">In Vitro Techniques</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Models, Molecular</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Oximes</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Positron-Emission Tomography</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Protein Binding</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Pyridines</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Rats, Sprague-Dawley</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Receptor, Metabotropic Glutamate 5</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Receptors, Metabotropic Glutamate</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Stereoisomerism</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Structure-Activity Relationship</dc:subject>
  <dc:title xmlns:ns19="xml" ns19:lang="en">Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET).</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
